What do analysts say about Medtronic stock? (2024)

What do analysts say about Medtronic stock?

Medtronic's analyst rating consensus is a Moderate Buy.

What is the outlook for Medtronic share?

What are analysts forecasts for Medtronic stock? The 50 analysts offering price forecasts for Medtronic have a median target of 100.76, with a high estimate of 135.00 and a low estimate of 77.00. The median estimate represents a 87.08 difference from the last price of 87.74.

What is Medtronic stock forecast for 2024?

According to our current MDT stock forecast, the value of Medtronic Plc shares will drop by -0.45% and reach $ 84.04 per share by February 21, 2024. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).

What are the analyst recommendations for MDT?

Based on analysts offering 12 month price targets for MDT in the last 3 months. The average price target is $89.33 with a high estimate of $102 and a low estimate of $72.

What is Medtronic stock prediction for 2025?

On average, Wall Street analysts predict that Medtronic's share price could reach $93.13 by Jan 12, 2025. The average Medtronic stock price prediction forecasts a potential upside of 9.92% from the current MDT share price of $84.72. What is MDT's forecast return on equity (ROE) for 2024-2027?

Will Medtronic stock recover?

MDT Stock 12 Months Forecast

Based on 18 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $90.25 with a high forecast of $104.00 and a low forecast of $72.00. The average price target represents a 6.53% change from the last price of $84.72.

Is Medtronic a good stock to buy?

Medtronic is known for being a great dividend stock, and with good reason. The company is inching closer to Dividend King status; it is currently on its 46th consecutive year of dividend increases.

Is Medtronic stock a buy or sell?

Still a buy

At recent prices, Medtronic shares offer an above-average 3.5% dividend yield. While its recent pace of dividend raises has been disappointing, new products on the market now and more on the way could drive growth at a high single-digit percentage in the coming decade.

Why buy Medtronic?

The financial health and growth prospects of MDT, demonstrate its potential to perform inline with the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.

What is the future growth of Medtronic?

Future Growth

Medtronic is forecast to grow earnings and revenue by 10.4% and 4.2% per annum respectively. EPS is expected to grow by 11.2% per annum. Return on equity is forecast to be 14% in 3 years.

What is Medtronic earnings prediction?

Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.26 per share in its forthcoming report, representing a decline of 3.1% year over year. Revenues are projected to reach $7.95 billion, increasing 2.9% from the same quarter last year.

What recommendation does an analyst report offer?

Analyst recommendations are recommendations and advice given by financial analysts and investment researchers to their clients with regards to what assets to invest in and what assets not to invest in. Modern financial markets are incredibly diverse, with different asset classes behaving differently at different times.

Who should lead MDT?

The role of chair can be carried out by any core member of the MDT and does not need to be from a specific discipline. The arrangements for chair of the MDTM should be determined locally.

Who owns the most shares of Medtronic?

According to the latest TipRanks data, approximately 40.96% of Medtronic (MDT) stock is held by retail investors. Who owns the most shares of Medtronic (MDT)? Vanguard owns the most shares of Medtronic (MDT).

Is Medtronic a blue chip stock?

Medtronic (MDT)

Medtronic, a standout blue-chip healthcare stock and member of the dividend aristocrats, is well-positioned for healthcare's future. This sentiment becomes clear with Medtronic's collaboration with Nvidia (NASDAQ:NVDA) to develop an AI-powered diagnostic platform.

When did Medtronic stock split?

The most recent stock split occured on September 27th, 1999. One MDT share bought prior to August 1st, 1980 would equal to 128 MDT shares today.

Why is Medtronic stock performing so poorly?

Many stocks performed well last year, but Medtronic (NYSE: MDT) wasn't one of them. The medical device giant failed to keep pace with broader equities, partly because it was still dealing with lingering pandemic-related issues, such as supply chain problems.

Why is Medtronic stock so low?

Medtronic's growth rate has been underwhelming in recent years. Growth is a priority now and Medtronic is selling off majority stake in slower-growing areas of its business. A return to normal in the healthcare industry should add more stability to Medtronic's operations.

Is Medtronic stock a good long term investment?

Medical device maker Medtronic (NYSE: MDT) offers investors a couple of ways to build wealth: through the stock's gains and through its dividend income. Over the past decade, the stock has risen by 55%, and when including the impact of its dividend, the total return is around 96%.

Is Medtronic a good dividend stock?

Medtronic has a history of dividend increases and is well-positioned for long-term growth in the healthcare industry. The company's financial performance has been solid, with stable margins and consistent free cash flow.

Is Medtronic in debt?

Total debt on the balance sheet as of October 2023 : $25.08 B. According to Medtronic's latest financial reports the company's total debt is $25.08 B. A company's total debt is the sum of all current and non-current debts.

Is Medtronic undervalued?

Medtronic is a medical technology firm with a below-market valuation and a high forward dividend yield. MDT has seen strong earnings growth and received FDA approval for a new device, with a positive outlook for future growth.

How often does Medtronic pay dividends?

When is Medtronic dividend payment date? Medtronic's next quarterly payment date is on Jan 12, 2024, when Medtronic shareholders who owned MDT shares before Dec 19, 2023 received a dividend payment of $0.69 per share. Add MDT to your watchlist to be reminded of MDT's next dividend payment.

Is Medtronic a profitable company?

It expects adjusted profit for fiscal 2024 to be between $5.19 and $5.21 per share, compared with its previous range of $5.13 and $5.19 per share. Revenue for the third quarter rose 4.7% to $8.09 billion, compared with LSEG estimates of $7.95 billion. Its adjusted profit also topped estimates by 4 cents.

Is Medtronic a defensive stock?

The good news for long-term investors looking to put money to work in defensive stocks is that there are still plenty of cheap defensive stocks worth considering. Morningstar equity analysts see room for growth in a number of high-quality, defensive names such as Veeva Systems VEEV and Medtronic MDT.


You might also like
Popular posts
Latest Posts
Article information

Author: Fredrick Kertzmann

Last Updated: 28/01/2024

Views: 6166

Rating: 4.6 / 5 (46 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Fredrick Kertzmann

Birthday: 2000-04-29

Address: Apt. 203 613 Huels Gateway, Ralphtown, LA 40204

Phone: +2135150832870

Job: Regional Design Producer

Hobby: Nordic skating, Lacemaking, Mountain biking, Rowing, Gardening, Water sports, role-playing games

Introduction: My name is Fredrick Kertzmann, I am a gleaming, encouraging, inexpensive, thankful, tender, quaint, precious person who loves writing and wants to share my knowledge and understanding with you.